Myelogenous Leukemia

• CLINICAL_TRIALS research · 2026-03-17
  Clinical Trial Update: A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation [Phase 2]

  This Phase 2 clinical trial protocol investigates a post-transplant cyclophosphamide–based graft-versus-host disease prophylaxis approach in…

• CLINICAL_TRIALS research · 2026-03-12
  Clinical Trial Update: Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases [NA]

  This entry reports an ongoing clinical trial evaluating myeloablative preparative regimens for umbilical cord blood transplantation across s…

• CLINICAL_TRIALS research · 2025-12-02
  Clinical Trial Update: Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML [Phase 1]

  A Phase I study of the selective nuclear export inhibitor KPT-330 (selinexor) in children with relapsed or refractory acute lymphoblastic le…

• CLINICAL_TRIALS research · 2025-02-21
  Clinical Trial Update: TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia [Phase 1]

  A US Phase I trial evaluating TGRX-678 for patients with refractory or advanced chronic myelogenous leukemia is currently recruiting.

• CLINICAL_TRIALS research · 2017-08-10
  Clinical Trial Update: Analysis of Genetic Factors Related to Predisposition and Prognosis of Hematological Malignancies in Israel

  A completed Israeli clinical trial analyzing genetic factors associated with predisposition and prognosis of hematologic malignancies, inclu…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2016-02-22
  Clinical Trial Update: Safety and Efficiency Study of Pioglitazone in Combination With Imatinib Mesylate to Treat Chronic Myelogenous Leukemia [Phase 2]

  A Phase 2 trial is evaluating the safety and efficacy of pioglitazone in combination with imatinib mesylate for chronic myelogenous leukemia…

• CLINICAL_TRIALS research · 2013-07-17
  Clinical Trial Update: Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission [Phase 4]

  Phase 4 clinical trial assessing the growth hormone–IGF-1 axis in children with chronic myelogenous leukemia in remission.